MedPath

Phase II trial of hypofractionated intensity modulated radiotherapy in patients with low risk prostate cancer

Not Applicable
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000022570
Lead Sponsor
Kitasato university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
55
Inclusion Criteria

Not provided

Exclusion Criteria

no psychological disease no long term steroid prescription severe diabetes mellitus no active infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cumulative toxicity rate at 3 years after treatment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath